tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Steven Seedhouse, 319 are a BUY (93.82%), 21 are a HOLD (6.18%).
Analyst Steven Seedhouse, currently employed at CANTOR FITZGERALD, carries an average stock price target met ratio of 40.31% that have a potential upside of 60.77% achieved within 266 days.
Steven Seedhouse’s has documented 606 price targets and ratings displayed on 48 stocks. The coverage is on Healthcare, Industrials, Financial Services sectors.
Most recent stock forecast was given on BCRX, BioCryst Pharmaceuticals at 30-Jun-2026.
Analyst best performing recommendations are on ATXS (ASTRIA THERAPEUTICS).
The best stock recommendation documented was for APLS (APELLIS PHARMACEUTICALS) at 3/18/2026. The price target of $31 was fulfilled within 13 days with a profit of $13.11 (73.28%) receiving and performance score of 56.37.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 28-Jul-2017
$205
$22.5 (12.33%)
5 years 2 months 4 days ago
(05-May-2021)
3/5 (60%)
$35.09 (20.65%)
938
Hold Since 03-May-2021
$173
$-9.5 (-5.21%)
$156
5 years 2 months 6 days ago
(03-May-2021)
17/29 (58.62%)
$2.73 (1.60%)
650
Hold Since 04-Feb-2021
$190
$7.5 (4.11%)
$190
5 years 2 months 13 days ago
(26-Apr-2021)
11/14 (78.57%)
$23 (13.77%)
420
Buy Since 06-Sep-2019
$175
$-7.5 (-4.11%)
$165
5 years 5 months 5 days ago
(04-Feb-2021)
3/3 (100%)
$19.41 (12.48%)
397
Buy Since 17-Jul-2017
$166
$-16.5 (-9.04%)
$175
5 years 5 months 5 days ago
(04-Feb-2021)
32/33 (96.97%)
$10.41 (6.69%)
867
Which stock is Steven Seedhouse is most bullish on?
Which stock is Steven Seedhouse is most reserved on?
What Year was the first public recommendation made by Steven Seedhouse?
